Researchers develop pH and redox-sensitive systems to reduce immunotherapy toxicity

[News]

Although cancer immunotherapy has transformed treatment by harnessing the immune system to eliminate tumors, only a small subset of patients benefit. Many solid tumors remain "cold," characterized by poor immune cell infiltration and resistance to immune checkpoint blockade (ICB).

More... (https://www.news-medical.net/news/20260515/Researchers-develop-pH-and-redox-sensitive-systems-to-reduce-immunotherapy-toxicity.aspx)